Biblio

Mir O, Brodowicz T, Italiano A, Wallet J, Blay J-Y, Bertucci F, Chevreau C, Piperno-Neumann S, Bompas E, Salas S et al..  2016.  Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. LANCET ONCOLOGY. 17:1732-1742.

Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard J-F, Cheze S, Graveleau J, Slama B, Audia S, Ebbo M et al..  2014.  Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. BLOOD. 124:3228-3236.

Pol S., Bourliere M., Lucier S., De Ledinghen V., Zoulim F., Dorival-Mouly C., Metivier S., Larrey D., Tran A., Hezode C. et al..  2015.  SAFETY AND EFFICACY OF THE COMBINATION DACLATASVIR-SOFOSBUVIR IN HCV GENOTYPE 1-MONO-INFECTED PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT ANRS CO22 HEPATHER. JOURNAL OF HEPATOLOGY. 62:S258-S259.

Abdulmalak G, Chevallier O, Falvo N, Di Marco L, Bertaut A, Moulin B, Abi-Khalil C, Gehin S, Charles P-E, Latournerie M et al..  2018.  Safety and efficacy of transcatheter embolization with Glubran (R) 2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients. ABDOMINAL RADIOLOGY. 43:723-733.

Pommier T, Guenancia C, Sagnard A, Ferrand B, Didier R, Fichot M, Laurent G, Morgant M-C, Bouchot O, Lorujis L.  2021.  Safety and Efficacy of Transcatheter Mitral Valve Replacement Guided by Intracardiac Echocardiography. JACC-CARDIOVASCULAR INTERVENTIONS. 14:1620-1622.

Silva PEugenio, Babault N, Mazullo JBatista, de Oliveira TPereira, Lemos BLeticia, Carvalho VOliveira, Durigan JLuiz Quagl.  2017.  Safety and feasibility of a neuromuscular electrical stimulation chronaxie-based protocol in critical ill patients: A prospective observational study. JOURNAL OF CRITICAL CARE. 37:141-148.

Yetisir F, Turk EAbaci, Guerin B, Gagoski BA, P. Grant E, Adalsteinsson E, Wald LL.  2021.  Safety and imaging performance of two-channel RF shimming for fetal MRI at 3T. MAGNETIC RESONANCE IN MEDICINE. 86:2810-2821.

Rey D, Piroth L, Wendling M-J, Miailhes P, Michel M-L, Dufour C, Haour G, Sogni P, Rohel A, Ajana F et al..  2015.  Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HBO4 B-BOOST): a multicentre, open-label, randomised controlled trial. LANCET INFECTIOUS DISEASES. 15:1283-1291.

Hunault M, Maillard N, Tanguy-Schmidt A, Himberlin C, Choufi B, Bonmati C, Couturier MAnne, Deconinck E, Marolleau JPierre, Orsini-Piocelle F et al..  2015.  Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (>= 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentr. BLOOD. 126

Blanc J, Deschasse C, Kodjikian L, Dot C, Bron A-M, Creuzot-Garcher C.  2018.  Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. 256:1441-1448.

Dauvissat J, Rizzo C, Lellouche H, Porterie J, Melac-Ducamp S, Locquet V, Travers V, Maillet B, Conrozier T.  2018.  Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial). CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS. 11:1179544118782901.

Jung K.H, Ataseven B., Verrill M., De Laurentiis M., Azim H.A, Pivot X., Al-Sakaff N., Lauer S., Shing M., Gligorov J..  2015.  Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses. EUROPEAN JOURNAL OF CANCER. 51:S318.

Gligorov J., Ataseven B., Verrill M., De Laurentiis M., Jung K.H, Azim H.A, Al-Sakaff N., Lauer S., Shing M., Pivot X. et al..  2017.  Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients. EUROPEAN JOURNAL OF CANCER. 82:237-246.

Lorscheidt S, Lamprecht A.  2016.  Safety assessment of nanoparticles for drug delivery by means of classic in vitro assays and beyond. EXPERT OPINION ON DRUG DELIVERY. 13:1545-1558.

Grandvuillemin A., Boulay A., Luu M., Delaunay P., Gouverneur A., Benevent J., Dautriche A..  2018.  Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:57.

Grandvuillemin A., Boulay A., Luu M., Delaunay P., Gouverneur A., Benevent J., Dautriche A..  2018.  Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:57.

Chevallier O, Guillen K, Comby P-O, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glele L-S, Loffroy R.  2021.  Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE. 10:2298.

Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NKumar, Rodriguez-Valdes PJ, Sarao V, Mishra SKumar, A. Saatci O, Mirete PUdaondo et al..  2020.  Safety of 6000 intravitreal dexamethasone implants. BRITISH JOURNAL OF OPHTHALMOLOGY. 104:39-46.

Gouy S., Selle F., Lanbaudie E., Guyon F., Fourchotte V., Pomel C., Colombo P.E, Kalbacher E., Martin-Francoise S., Fauvet R. et al..  2015.  SAFETY OF BEVACIZUMAB CONTAINING NEOADJUVANT THERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY IN ADVANCED OVARIAN CANCER: DATA FROM THE ANTHALYA TRIAL. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 25:441-442.

Selle F., Gouy S., Lambaudie E., Guyon F., Fourchotte V., Pomel C., Colombo P.E, Kalbacher E., Martin-Francoise S., Fauvet R. et al..  2015.  Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial. EUROPEAN JOURNAL OF CANCER. 51:S553.

Frederic M., Delphine W.V, Prati C., Wendling D., Verhoeven F..  2021.  SAFETY OF BIOLOGIC TREATMENTS IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 80:719.

Bereau M., Clerc C., Jary A., Lavier A., Chamard L., Magnin E., Berger E..  2016.  Safety of Dimethylfumarate in clinical practice: a regional study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 30:81.

Karsenti D, Caillol F, Chaput U, Perrot B, Koch S, Vuitton L, Jacques J, Valats J-C, Poincloux L, Subtil C et al..  2020.  Safety of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Pancreatic Solid Pseudopapillary Neoplasm Before Surgical Resection A European Multicenter Registry-Based Study on 149 Patients. PANCREAS. 49:34-38.

Luu M, Benzenine E, Barkun A, Doret M, Michiels C, Degand T, Quantin C, Bardou M.  2019.  Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF alpha agents: a French nationwide population-based cohort. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50:1181-1188.

Luu M, Benzenine E, Barkun A, Doret M, Michiels C, Degand T, Quantin C, Bardou M.  2019.  Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF alpha agents: a French nationwide population-based cohort. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50:1181-1188.